A Double-Blind Placebo–Controlled, Multicenter, Cross-Over, Dose-Ranging Study to Compare the Efficacy and Safety of Albuterol Spiromax and Proair HFA in Adult and Adolescent Patients Ages 12 and Older with Persistent Asthma
Journal of Allergy and Clinical Immunology(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要